SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

Related

• 

  Comparing Outcomes of Standard and Reduced-Fluence Photodynamic Therapy in the Treatment of Polypoidal Choroidal Vasculopathy

  Colin S Tan, MBBS, MMed (Ophth), FRCSEd (Ophth)

  Annual Meeting Talks

  2018

• 

  Complications or Are They: Why We Can NEVER Get Enough ReST

  Jeffrey S. Heier, MD

  Peter K. Kaiser, MD FASRS

  Geoffrey G. Emerson, MD, PhD, FASRS

  J. Michael Jumper, MD, FASRS

  Ehab N. ELRAYES, MD, PhD ,FASRS

  Daniel Simhaee, MD

  ASSAF DOTAN, MD

  Paul Hahn, MD, PhD, FASRS

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2018

• 

  ASRS Presidents' Retina Young Investigators Award, Advancing Insights Into Diabetic Eye Disease, Rishi P. Singh, MD

  Rishi P. Singh, MD

  Annual Meeting Talks

  2018